Related Experiment Video
Updated: Jul 31, 2026
08:51
Evaluation of Polymeric Gene Delivery Nanoparticles by Nanoparticle Tracking Analysis and High-throughput Flow Cytometry
Published on: March 1, 2013
Development of plasmid and oligonucleotide nanometric particles
1Laboratoire de Chimie Génétique associé CNRS/Université Louis Pasteur de Strasbourg, Faculté de Pharmacie, Illkirch, France.
Gene Therapy
|May 29, 2002
Summary
Researchers developed novel 30 nm nanoparticles for improved nucleic acid delivery. These compact DNA particles enhance in vivo diffusion and intracellular trafficking, overcoming key clinical limitations for gene therapy vectors.
Area of Science:
- Biotechnology
- Nanomedicine
- Molecular Biology
Background:
- Nucleic acid delivery vectors show therapeutic promise but face clinical hurdles due to poor biodistribution and intracellular trafficking.
- Particle size is critical for in vivo diffusion and nuclear gene delivery.
Purpose of the Study:
- To develop novel cationic thiol-detergents for compacting plasmid DNA into small, stable nanoparticles.
- To assess the physicochemical properties and potential for improved delivery of these nanoparticles.
Main Methods:
- Development of cationic thiol-detergents to individually compact plasmid DNA molecules.
- Stabilization of DNA nanoparticles via air-induced disulfide lipid formation.
- Characterization of particle size (approx. 30 nm) and gel electrophoretic mobility.
- Coating nanoparticles with poly(ethylene glycol) (PEG) to enhance biodistribution.
Main Results:
- Successfully created uniform, approximately 30 nm DNA nanoparticles, corresponding to single plasmid DNA molecules.
- Demonstrated increased gel electrophoretic mobility of the anionic nanoparticles compared to naked DNA.
- Oligonucleotide-based particles measured 19 nm, indicating size control.
- PEGylation was employed to potentially improve nanoparticle biodistribution.
Conclusions:
- The developed nanoparticles offer a promising approach to overcome limitations in nucleic acid delivery.
- The controlled size (30 nm) and enhanced mobility suggest improved in vivo diffusion and intracellular trafficking.
- The particle size is compatible with nuclear pore transport, facilitating gene delivery.
